• KYTX: KYV-101 delivers transformative results in autoimmune diseases, targeting first-to-market leadership TradingView Mon, 17 Nov 2025 14:27:13 GMT
• KYTX: KYV101 demonstrates transformative efficacy and safety in autoimmune diseases, targeting first-to-market leadership TradingView Mon, 17 Nov 2025 14:16:43 GMT
• How sentiment analysis helps forecast Kyverna Therapeutics Inc. - 2025 Volatility Report & Real-Time Market Trend Scan newser.com Mon, 17 Nov 2025 10:15:48 GMT
• Is Kyverna Therapeutics Inc. stock attractive for passive investors - Earnings Performance Report & Accurate Buy Signal Notificati... newser.com Sun, 16 Nov 2025 22:47:22 GMT
• How sentiment analysis helps forecast Kyverna Therapeutics Inc. - Rate Hike & Low Risk Entry Point Tips newser.com Sun, 16 Nov 2025 15:29:26 GMT
• Why Kyverna Therapeutics Inc. stock remains undervalued - July 2025 PostEarnings & Real-Time Buy Zone Alerts newser.com Sun, 16 Nov 2025 09:55:20 GMT
• Is Kyverna Therapeutics Inc. stock vulnerable to regulatory risks - 2025 Buyback Activity & Free Safe Capital Growth Stock Tips newser.com Sun, 16 Nov 2025 05:53:17 GMT
• Is Kyverna Therapeutics Inc. stock vulnerable to regulatory risks - Trade Analysis Summary & Daily Profit Maximizing Tips newser.com Sat, 15 Nov 2025 21:17:49 GMT
• Is Kyverna Therapeutics Inc. stock attractive for passive investors - 2025 Earnings Impact & Short-Term High Return Ideas newser.com Sat, 15 Nov 2025 12:54:49 GMT
• why kyverna therapeutics inc. stock remains undervalued - jobs report & community verified watchlist alerts newser.com Sat, 15 Nov 2025 11:47:40 GMT
• What the charts say about Kyverna Therapeutics Inc. today - July 2025 Rallies & Safe Swing Trade Setup Alerts newser.com Sat, 15 Nov 2025 08:14:31 GMT
• Is Kyverna Therapeutics Inc. stock attractive for passive investors - Weekly Stock Summary & Weekly High Potential Alerts newser.com Fri, 14 Nov 2025 22:15:15 GMT
• why kyverna therapeutics inc. stock remains undervalued - quarterly market review & real-time volume trigger notifications newser.com Fri, 14 Nov 2025 17:44:39 GMT
• What analyst consensus says on Kyverna Therapeutics Inc. stock - July 2025 Update & Stepwise Trade Signal Guides Fundação Cultural do Pará Fri, 14 Nov 2025 13:04:24 GMT
• How sentiment analysis helps forecast Kyverna Therapeutics Inc. - 2025 Earnings Impact & Accurate Intraday Trading Signals newser.com Fri, 14 Nov 2025 11:02:51 GMT
• Kyverna Therapeutics: Immune Reset Is Clinically Validated, Market Ignores Potential Seeking Alpha Fri, 14 Nov 2025 07:24:24 GMT
• Kyverna Therapeutics (NASDAQ:KYTX) Issues Quarterly Earnings Results, Beats Estimates By $0.12 EPS MarketBeat Fri, 14 Nov 2025 01:55:57 GMT
• What the charts say about Kyverna Therapeutics Inc. today - Weekly Gains Summary & Long-Term Capital Growth Ideas newser.com Thu, 13 Nov 2025 21:37:15 GMT
• what drives kyverna therapeutics inc stock price - institutional holding changes & affordable investment portfolio earlytimes.in Thu, 13 Nov 2025 19:17:02 GMT
• Kyverna Therapeutics: Promising Clinical Progress and Strategic Execution Support Buy Rating TipRanks Thu, 13 Nov 2025 12:27:18 GMT
• Kyverna Therapeutics: Strategic Advancements and Financial Stability Underpin Buy Rating TipRanks Thu, 13 Nov 2025 10:26:31 GMT
• Is Kyverna Therapeutics Inc. stock vulnerable to regulatory risks - Weekly Trade Review & Daily Profit Maximizing Tips newser.com Thu, 13 Nov 2025 07:15:10 GMT
• How sentiment analysis helps forecast Kyverna Therapeutics Inc. - July 2025 Catalysts & Entry and Exit Point Strategies newser.com Thu, 13 Nov 2025 06:03:05 GMT
• Kyverna Therapeutics Reports Increased Losses Amid R&D Focus TipRanks Thu, 13 Nov 2025 05:02:47 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - market trend report & free real-time volume trigger notification... newser.com Wed, 12 Nov 2025 23:06:02 GMT
• Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results The Manila Times Wed, 12 Nov 2025 21:28:50 GMT
• is kyverna therapeutics inc. stock vulnerable to regulatory risks - market performance report & free long-term investment growth p... newser.com Wed, 12 Nov 2025 21:17:33 GMT
• Kyverna Therapeutics Reports Milestones in Clinical Trials for Stiff Person Syndrome and Myasthenia Gravis, Secures $150M Loan Fac... Quiver Quantitative Wed, 12 Nov 2025 21:15:00 GMT
• Kyverna (Nasdaq: KYTX) targets SPS topline in early 2026; BLA submission planned 1H 2026 Stock Titan Wed, 12 Nov 2025 21:05:00 GMT
• why kyverna therapeutics inc. stock remains undervalued - weekly market report & comprehensive market scan reports newser.com Wed, 12 Nov 2025 20:36:56 GMT
• Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Rating of "Moderate Buy" from Analysts MarketBeat Wed, 12 Nov 2025 09:57:13 GMT
• what the charts say about kyverna therapeutics inc. today - july 2025 catalysts & smart investment allocation insights newser.com Wed, 12 Nov 2025 06:30:23 GMT
• myasthenia gravis market is expected to grow at a cagr of 10.4% by 2034, estimates delveinsight Barchart.com Tue, 11 Nov 2025 19:41:15 GMT
• what the charts say about kyverna therapeutics inc. today - product launch & real-time buy signal notifications newser.com Tue, 11 Nov 2025 11:15:01 GMT
• is kyverna therapeutics inc. stock attractive for passive investors - 2025 endofyear setup & verified trade idea suggestions newser.com Mon, 10 Nov 2025 14:10:11 GMT
• Y Intercept Hong Kong Ltd Invests $129,000 in Kyverna Therapeutics, Inc. $KYTX MarketBeat Mon, 10 Nov 2025 13:55:37 GMT
• Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference GlobeNewswire Mon, 10 Nov 2025 13:00:00 GMT
• Kyverna Therapeutics (NASDAQ: KYTX) sets Nov. 17 talk at Jefferies London; with webcast Stock Titan Mon, 10 Nov 2025 13:00:00 GMT
• kyverna therapeutics inc stock analysis and forecast - technical pattern recognition & small budget investment tips earlytimes.in Mon, 10 Nov 2025 10:51:41 GMT
• why kyverna therapeutics inc. stock remains undervalued - dollar strength & free high accuracy swing entry alerts newser.com Mon, 10 Nov 2025 09:38:18 GMT
• can machine learning forecast kyverna therapeutics inc. recovery - wall street watch & verified momentum stock watchlist newser.com Mon, 10 Nov 2025 08:48:01 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - quarterly investment review & weekly watchlist of top performers... newser.com Mon, 10 Nov 2025 06:50:35 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - quarterly profit review & fast exit and entry strategy plans newser.com Mon, 10 Nov 2025 06:21:57 GMT
• combining price and volume data for kyverna therapeutics inc. - weekly risk report & entry and exit point strategies newser.com Mon, 10 Nov 2025 03:44:48 GMT
• is kyverna therapeutics inc. stock vulnerable to regulatory risks - july 2025 weekly recap & advanced swing trade entry plans newser.com Mon, 10 Nov 2025 03:36:13 GMT
• is kyverna therapeutics inc. stock attractive for passive investors - quarterly portfolio summary & free low drawdown momentum tra... newser.com Sun, 09 Nov 2025 19:30:49 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - 2025 short interest & intraday high probability setup alerts newser.com Sun, 09 Nov 2025 12:31:12 GMT
• Kyverna Therapeutics Inc expected to post a loss of 97 cents a share - Earnings Preview TradingView Fri, 07 Nov 2025 23:23:05 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - rate hike & fast exit strategy with risk control newser.com Fri, 07 Nov 2025 16:18:42 GMT
• is kyverna therapeutics inc. stock vulnerable to regulatory risks - quarterly market review & risk managed investment strategies newser.com Fri, 07 Nov 2025 15:41:01 GMT
• is kyverna therapeutics inc. stock attractive for passive investors - gap down & precise buy zone tips newser.com Thu, 06 Nov 2025 18:39:56 GMT
• Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday MarketBeat Thu, 06 Nov 2025 12:56:41 GMT
• can machine learning forecast kyverna therapeutics inc. recovery - 2025 valuation update & precise buy zone tips newser.com Thu, 06 Nov 2025 11:42:26 GMT
• guidance update: why kyverna therapeutics inc. stock remains undervalued - 2025 investor takeaways & fast gain swing alerts Fundação Cultural do Pará Thu, 06 Nov 2025 11:35:09 GMT
• why kyverna therapeutics inc. stock remains undervalued - portfolio risk summary & risk adjusted swing trade ideas newser.com Thu, 06 Nov 2025 10:45:52 GMT
• what the charts say about kyverna therapeutics inc. today - july 2025 closing moves & weekly market pulse alerts newser.com Thu, 06 Nov 2025 08:51:11 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - 2025 market sentiment & growth focused investment plans newser.com Thu, 06 Nov 2025 08:08:06 GMT
• is kyverna therapeutics inc. stock recession proof - rate cut & expert verified stock movement alerts Fundação Cultural do Pará Thu, 06 Nov 2025 07:06:39 GMT
• will kyverna therapeutics inc. stock keep outperforming rivals - july 2025 pullbacks & safe entry zone tips Fundação Cultural do Pará Thu, 06 Nov 2025 05:07:49 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - july 2025 opening moves & community driven trade alerts newser.com Thu, 06 Nov 2025 01:29:55 GMT
• why kyverna therapeutics inc. stock remains undervalued - july 2025 selloffs & breakout confirmation trade signals newser.com Wed, 05 Nov 2025 15:47:24 GMT
• will kyverna therapeutics inc. stock keep outperforming rivals - july 2025 rallies & risk controlled swing alerts Fundação Cultural do Pará Wed, 05 Nov 2025 15:19:26 GMT
• how kyverna therapeutics inc. stock reacts to bond yields - earnings overview summary & pattern based trade signal system fcp.pa.gov.br Wed, 05 Nov 2025 14:44:30 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - 2025 earnings impact & short-term trading opportunity alerts newser.com Wed, 05 Nov 2025 12:02:11 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - july 2025 news drivers & weekly breakout opportunity watchlist newser.com Wed, 05 Nov 2025 11:08:34 GMT
• what the charts say about kyverna therapeutics inc. today - july 2025 movers & smart swing trading techniques newser.com Wed, 05 Nov 2025 08:40:07 GMT
• caribou biosciences reports clinical data on allogeneic car t therapies while kyverna therapeutics advances autoimmune program geneonline.com Wed, 05 Nov 2025 08:02:59 GMT
• is kyverna therapeutics inc. stock a buy before product launches - trade exit summary & entry point confirmation alerts newser.com Wed, 05 Nov 2025 07:06:02 GMT
• using economic indicators to assess kyverna therapeutics inc. potential - july 2025 rallies & free safe entry trade signal reports... newser.com Wed, 05 Nov 2025 05:53:48 GMT
• can machine learning forecast kyverna therapeutics inc. recovery - quarterly earnings summary & fast momentum entry tips newser.com Wed, 05 Nov 2025 00:13:17 GMT
• fda's rigid approach adds uncertainty to uniqure's accelerated pathway for huntington's gene therapy Sahm Tue, 04 Nov 2025 19:30:00 GMT
• why kyverna therapeutics inc. stock remains undervalued - market rally & weekly high return opportunities newser.com Tue, 04 Nov 2025 17:45:50 GMT
• is kyverna therapeutics inc. stock attractive for passive investors - earnings trend report & daily growth stock tips newser.com Tue, 04 Nov 2025 09:29:25 GMT
• is kyverna therapeutics inc. stock vulnerable to regulatory risks - 2025 growth vs value & real-time volume triggers newser.com Tue, 04 Nov 2025 09:16:56 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - 2025 market outlook & verified short-term trading plans newser.com Tue, 04 Nov 2025 08:56:50 GMT
• what the charts say about kyverna therapeutics inc. today - portfolio return summary & expert-curated trade recommendations newser.com Tue, 04 Nov 2025 08:22:37 GMT
• kyverna secures $150 million loan facility to advance autoimmune therapies by investing.com Investing.com Nigeria Tue, 04 Nov 2025 03:22:48 GMT
• is kyverna therapeutics inc. stock attractive for passive investors - weekly trade summary & long-term safe investment ideas fcp.pa.gov.br Mon, 03 Nov 2025 19:48:11 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - wall street watch & low drawdown trading strategies newser.com Mon, 03 Nov 2025 14:29:42 GMT
• is kyverna therapeutics inc. stock vulnerable to regulatory risks - fed meeting & growth focused stock pick reports newser.com Mon, 03 Nov 2025 14:15:42 GMT
• how sentiment analysis helps forecast kyverna therapeutics inc. - trade ideas & high accuracy swing entry alerts newser.com Mon, 03 Nov 2025 12:01:51 GMT
• will kyverna therapeutics inc. stock deliver long term returns - market growth review & weekly market pulse alerts newser.com Mon, 03 Nov 2025 11:35:05 GMT
• combining price and volume data for kyverna therapeutics inc. - weekly trade summary & safe entry momentum tips newser.com Mon, 03 Nov 2025 10:52:07 GMT
• using economic indicators to assess kyverna therapeutics inc. potential - weekly trade recap & free low drawdown momentum trade id... newser.com Mon, 03 Nov 2025 09:43:09 GMT
• can machine learning forecast kyverna therapeutics inc. recovery - trade entry summary & high accuracy trade alerts newser.com Mon, 03 Nov 2025 08:38:19 GMT
• Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance Yahoo Finance Mon, 03 Nov 2025 08:00:00 GMT
• We're Keeping An Eye On Kyverna Therapeutics' (NASDAQ:KYTX) Cash Burn Rate simplywall.st Mon, 03 Nov 2025 08:00:00 GMT
• Kyverna (Nasdaq: KYTX) secures up to $150M non-dilutive financing maturing 2030 Stock Titan Mon, 03 Nov 2025 08:00:00 GMT
• Kyverna Therapeutics secures up to $150M in non-dilutive financing TipRanks Mon, 03 Nov 2025 08:00:00 GMT
• kyverna secures $150 million loan facility to advance autoimmune therapies Investing.com Mon, 03 Nov 2025 08:00:00 GMT
• what the charts say about kyverna therapeutics inc. today - portfolio growth summary & capital efficiency focused ideas newser.com Mon, 03 Nov 2025 07:23:55 GMT
• what the charts say about kyverna therapeutics inc. today - 2025 trading volume trends & weekly high return stock opportunities newser.com Sun, 02 Nov 2025 10:01:07 GMT
• combining price and volume data for kyverna therapeutics inc. - july 2025 selloffs & consistent income trade ideas newser.com Sun, 02 Nov 2025 09:22:46 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - july 2025 opening moves & weekly high return stock forecasts newser.com Sun, 02 Nov 2025 08:34:34 GMT
• is kyverna therapeutics inc. stock a buy before product launches - trade analysis report & daily risk controlled trade plans newser.com Sun, 02 Nov 2025 08:01:59 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - inflation watch & fast entry momentum alerts newser.com Sat, 01 Nov 2025 16:27:08 GMT
• kyverna therapeutics announces data from phase 2 from kysa-6 clinical trial MSN Sat, 01 Nov 2025 08:13:45 GMT
• what the charts say about kyverna therapeutics inc. today - 2025 stock rankings & daily stock momentum reports newser.com Sat, 01 Nov 2025 07:02:34 GMT
• analysts conflicted on these healthcare names: kyverna therapeutics, inc. (kytx), disc medicine (iron) and baxter international (b... The Globe and Mail Fri, 31 Oct 2025 13:39:02 GMT
• will kyverna therapeutics inc. stock deliver long term returns - 2025 risk factors & safe capital growth trade ideas newser.com Fri, 31 Oct 2025 10:09:55 GMT
• what the charts say about kyverna therapeutics inc. today - index update & fast exit/entry strategy plans newser.com Fri, 31 Oct 2025 08:08:34 GMT
• naji gehchan, md, mba, on evaluating car-t kyv-101 for generalized myasthenia gravis CGTLive® Fri, 31 Oct 2025 07:00:00 GMT
• pattern recognition hints at kyverna therapeutics inc. upside - market growth summary & reliable breakout stock forecasts newser.com Thu, 30 Oct 2025 14:59:57 GMT
• what the charts say about kyverna therapeutics inc. today - 2025 geopolitical influence & advanced swing trade entry plans newser.com Thu, 30 Oct 2025 14:55:46 GMT
• kyverna’s car t therapy sets ’new efficacy standard’ in myasthenia gravis, de-risking phase iii trials BioSpace Thu, 30 Oct 2025 11:51:09 GMT
• kyverna therapeutics price target raised to $31 from $27 at wells fargo TipRanks Thu, 30 Oct 2025 11:25:25 GMT
• combining price and volume data for kyverna therapeutics inc. - price action & fast gaining stock reports newser.com Thu, 30 Oct 2025 08:21:03 GMT
• Kyverna’s CAR T Therapy Sets 'New Efficacy Standard' in Myasthenia Gravis, De-Risking Phase III Trials BioSpace Thu, 30 Oct 2025 07:00:00 GMT
• promising phase 2 data and favorable safety profile drive buy rating for kyverna therapeutics’ kyv-101 TipRanks Thu, 30 Oct 2025 07:00:00 GMT
• is kyverna therapeutics inc. stock a buy before product launches - weekly stock analysis & weekly top gainers trade list newser.com Thu, 30 Oct 2025 05:48:34 GMT
• wells fargo maintains kyverna therapeutics(kytx.us) with buy rating, raises target price to $31 富途牛牛 Thu, 30 Oct 2025 05:10:34 GMT
• william blair maintains kyverna therapeutics(kytx.us) with buy rating 富途牛牛 Thu, 30 Oct 2025 03:53:03 GMT
• kyverna therapeutics (kytx) price target increased by 16.46% to 23.46 Nasdaq Wed, 29 Oct 2025 20:15:00 GMT
• william blair maintains kyverna therapeutics(kytx.us) with buy rating 富途牛牛 Wed, 29 Oct 2025 18:31:00 GMT
• is kyverna therapeutics inc. stock a buy before product launches - trade risk assessment & consistent growth equity picks newser.com Wed, 29 Oct 2025 11:59:24 GMT
• what the charts say about kyverna therapeutics inc. today - july 2025 outlook & intraday high probability setup alerts newser.com Wed, 29 Oct 2025 10:01:27 GMT
• using economic indicators to assess kyverna therapeutics inc. potential - market sentiment summary & risk adjusted buy/sell alerts... newser.com Wed, 29 Oct 2025 08:57:31 GMT
• Kyverna links CAR-T to improved autoimmune outcomes in small trial Fierce Biotech Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics Announces Positive Interim Phase 2 GlobeNewswire Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics Reports Promising Interim Results from Phase 2 Trial of KYV-101 in Generalized Myasthenia Gravis, Setting a N... Quiver Quantitative Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna (Nasdaq: KYTX): 100% MG-ADL and QMG response in gMG Phase 2; no ICANS Stock Titan Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna says small group of rare disease patients all responded to its CAR-T Endpoints News Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics Reports Positive Phase 2 Trial Results TipRanks Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics stock surges after positive myasthenia gravis trial data Investing.com Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics’ KYV-101 Shows Promising Phase II Results in gMG, Supporting Buy Rating TipRanks Wed, 29 Oct 2025 07:00:00 GMT
• Amen at AANEM: Kyverna makes good on MG phase II promise BioWorld MedTech Wed, 29 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics price target raised to $31 from $27 at Wells Fargo TipRanks Wed, 29 Oct 2025 07:00:00 GMT
• kyverna therapeutics announces data from phase 2 from kysa-6 clinical trial TipRanks Wed, 29 Oct 2025 07:00:00 GMT
• kyverna links car-t to autoimmune improvements in small trial Fierce Biotech Wed, 29 Oct 2025 07:00:00 GMT
• wells fargo maintains kyverna therapeutics(kytx.us) with buy rating, raises target price to $31 富途牛牛 Wed, 29 Oct 2025 07:00:00 GMT
• will kyverna therapeutics inc. stock deliver long term returns - global markets & community shared stock ideas newser.com Wed, 29 Oct 2025 06:39:34 GMT
• is kyverna therapeutics inc. stock a buy before product launches - july 2025 fed impact & precise buy zone tips newser.com Tue, 28 Oct 2025 11:05:13 GMT
• using economic indicators to assess kyverna therapeutics inc. potential - portfolio return summary & real-time volume analysis ale... newser.com Tue, 28 Oct 2025 08:59:22 GMT
• can machine learning forecast kyverna therapeutics inc. recovery - trade risk report & long-term safe return strategies newser.com Tue, 28 Oct 2025 07:27:14 GMT
• is kyverna therapeutics inc. stock a defensive play in 2025 - recession risk & precise trade entry recommendations fcp.pa.gov.br Tue, 28 Oct 2025 06:21:36 GMT
• kyverna therapeutics advances car t-cell therapy study for myasthenia gravis TipRanks Tue, 28 Oct 2025 00:20:37 GMT
• how strong is kyverna therapeutics inc. stock balance sheet - july 2025 preearnings & technical pattern based signals fcp.pa.gov.br Mon, 27 Oct 2025 14:06:10 GMT
• Kyverna Therapeutics price target raised to $20 from $10 at H.C. Wainwright TipRanks Mon, 27 Oct 2025 10:56:46 GMT
• using economic indicators to assess kyverna therapeutics inc. potential - quarterly trade summary & verified short-term plans newser.com Mon, 27 Oct 2025 07:13:10 GMT
• Kyverna Therapeutics (NASDAQ:KYTX) Given New $20.00 Price Target at HC Wainwright MarketBeat Mon, 27 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics stock price target raised to $20 from $10 at H.C. Wainwright Investing.com Mon, 27 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics Advances in Lupus Nephritis Treatment with KYV-101 CAR T-Cell Therapy TipRanks Mon, 27 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics Advances with Promising CAR-T Therapy for Stiff Person Syndrome TipRanks Mon, 27 Oct 2025 07:00:00 GMT
• Kyverna Therapeutics Advances CAR T-Cell Therapy Study for Myasthenia Gravis TipRanks Mon, 27 Oct 2025 07:00:00 GMT
Kyverna Therapeutics Inc(NASDAQ:KYTX) 
Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today reported its business highlights and financial results for the second quarter ended June 30, 2024.
Share this website to your friends